Q1 2018 Vital Therapies Inc Earnings Call
Conference Call Vital Therapies Inc
Vital Therapies Inc Conference call will be held on May 8, 2018. During the earnings conference call's session Vital Therapies Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Vital Therapies Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are a biotherapeutic company focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Our product candidate, the ELAD® System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's own liver to potentially regenerate to a healthy state, or to stabilize the patient until transplant. The ELAD System is the only liver support system containing immortal human liver-derived cells, or VTL C3A cells, to enter phase 3 clinical trials. We designed the ELAD System to supplement key aspects of normal liver function to improve patient survival.Read more Conference Call